Pentti Seppälä

929 total citations
33 papers, 738 citations indexed

About

Pentti Seppälä is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Pentti Seppälä has authored 33 papers receiving a total of 738 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Pentti Seppälä's work include Diabetes Management and Research (5 papers), Diabetes and associated disorders (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Pentti Seppälä is often cited by papers focused on Diabetes Management and Research (5 papers), Diabetes and associated disorders (3 papers) and Proteoglycans and glycosaminoglycans research (3 papers). Pentti Seppälä collaborates with scholars based in Finland, United States and Denmark. Pentti Seppälä's co-authors include Jorma Viikari, T Tulokas, Leo Niskanen, L. Ryysy, Sulo Rajala, Marja‐Riitta Taskinen, Eila Kujansuu, Marjut Kauppila, Aapo Lehtonen and Hannele Yki‐Järvinen and has published in prestigious journals such as New England Journal of Medicine, The Journal of Clinical Endocrinology & Metabolism and Gut.

In The Last Decade

Pentti Seppälä

32 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pentti Seppälä Finland 13 459 207 193 134 80 33 738
Angela McDonald United Kingdom 12 153 0.3× 310 1.5× 493 2.6× 155 1.2× 47 0.6× 16 756
C T Chan United States 10 127 0.3× 118 0.6× 156 0.8× 40 0.3× 16 0.2× 12 485
S. M. Swift United Kingdom 13 164 0.4× 358 1.7× 142 0.7× 183 1.4× 20 0.3× 31 638
Dinesh Bhatnagar India 14 99 0.2× 207 1.0× 230 1.2× 85 0.6× 24 0.3× 28 651
Andrew G. Breite United States 12 117 0.3× 283 1.4× 173 0.9× 112 0.8× 77 1.0× 18 504
Cristina Tortoioli Italy 12 179 0.4× 106 0.5× 105 0.5× 185 1.4× 16 0.2× 18 599
M. Saluja United States 9 75 0.2× 828 4.0× 149 0.8× 50 0.4× 66 0.8× 17 965
Vidya S. Farook United States 13 63 0.1× 144 0.7× 198 1.0× 122 0.9× 62 0.8× 29 515
Albert M. Song United States 10 56 0.1× 437 2.1× 120 0.6× 52 0.4× 56 0.7× 13 593
J. M. Katz New Zealand 8 61 0.1× 45 0.2× 150 0.8× 30 0.2× 33 0.4× 14 415

Countries citing papers authored by Pentti Seppälä

Since Specialization
Citations

This map shows the geographic impact of Pentti Seppälä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pentti Seppälä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pentti Seppälä more than expected).

Fields of papers citing papers by Pentti Seppälä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pentti Seppälä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pentti Seppälä. The network helps show where Pentti Seppälä may publish in the future.

Co-authorship network of co-authors of Pentti Seppälä

This figure shows the co-authorship network connecting the top 25 collaborators of Pentti Seppälä. A scholar is included among the top collaborators of Pentti Seppälä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pentti Seppälä. Pentti Seppälä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yki‐Järvinen, Hannele, L. Ryysy, Marjut Kauppila, et al.. (1997). Effect of Obesity on the Response to Insulin Therapy in Noninsulin-Dependent Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 82(12). 4037–4043. 101 indexed citations
2.
Kuusi, T, Matti Jauhiainen, Christian Ehnholm, et al.. (1995). Effect of insulin treatment on serum lipoprotein(a) in non‐insulin‐dependent diabetes. European Journal of Clinical Investigation. 25(3). 194–200. 11 indexed citations
3.
Kauppila, Marjut, Eila Kujansuu, Leo Niskanen, et al.. (1993). Comparison of Insulin Regimens in Patients with Non-Insulin Dependent Diabetes Mellitus. The Endocrinologist. 3(2). 159–159. 7 indexed citations
4.
Yki‐Järvinen, Hannele, Marjut Kauppila, Eila Kujansuu, et al.. (1992). Comparison of Insulin Regimens in Patients with Non-Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine. 327(20). 1426–1433. 248 indexed citations
5.
Nuutila, Pirjo, Pertti Koskinen, Kerttu Irjala, et al.. (1990). Two new two-step immunoassays for free thyroxin evaluated: solid-phase radioimmunoassay and time-resolved fluoroimmunoassay. Clinical Chemistry. 36(7). 1355–1360. 18 indexed citations
6.
Välimäki, Matti, Risto Pelkonen, K. Huikuri, et al.. (1989). Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. European Journal of Endocrinology. 121(1). 67–72. 53 indexed citations
7.
Soppi, Esa, et al.. (1986). Unusual association of hyperkalemia and hypertension.. Hypertension. 8(2). 174–177. 20 indexed citations
8.
Koskinen, Pertti, et al.. (1986). Plasma and urinary C-peptide in the classification of adult diabetics. Scandinavian Journal of Clinical and Laboratory Investigation. 46(7). 655–663. 25 indexed citations
9.
Viikari, Jorma, et al.. (1985). C-peptide determination in the choice of treatment in diabetes mellitus. Scandinavian Journal of Clinical and Laboratory Investigation. 45(7). 589–597. 30 indexed citations
10.
Koivisto, Veikko A, A. Aro, Kari Cantell, et al.. (1984). Remissions in newly diagnosed Type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy. Diabetologia. 27(2). 193–197. 30 indexed citations
11.
Tammi, Markku, et al.. (1978). Connective tissue components in normal and atherosclerotic human coronary arteries. Atherosclerosis. 29(2). 191–194. 57 indexed citations
12.
Syvälahti, Erkka, Pentti Seppälä, & E Iisalo. (1975). Growth Hormone and Cortisol Secretion after Oral and Intravenous Administration of Methyldopa. Acta Pharmacologica et Toxicologica. 37(3). 257–264. 4 indexed citations
13.
Vuori, Ilkka, Eino Heikkinen, & Pentti Seppälä. (1969). Physical fitness of university students.. PubMed. 9(1). 40–8. 1 indexed citations
14.
Seppälä, Pentti, Aapo Lehtonen, Jorma Kärkkäinen, & V. Näntö. (1967). The presence of chondroitin sulphate in the synovial fluid in rheumatoid arthritis. Clinica Chimica Acta. 16(1). 115–119. 14 indexed citations
15.
Oka, Martti, et al.. (1966). Latex Slide Test in Thyroid Diseases. Acta Medica Scandinavica. 179(2). 253–255. 1 indexed citations
16.
Kulonen, E., et al.. (1966). Physicochemical properties of synovial fluid with reference to rheumatoid disease and the effect of hydrocortisone treatment.. PubMed. 25(3). 1141–3. 5 indexed citations
17.
Simons, Kai, Kimmo Aho, Pentti Seppälä, & O Wäger. (1964). Purification of the rheumatoid factor. Clinica Chimica Acta. 9(6). 519–525. 4 indexed citations
18.
Seppälä, Pentti, et al.. (1962). Redundant colon as a cause of constipation. Gut. 3(2). 140–141. 15 indexed citations
19.
Seppälä, Pentti, T. Nikkari, & V. Näntö. (1961). Physical Chemical Properties of a Urinary Protein in a Case of Multiple Myeloma. Scandinavian Journal of Clinical and Laboratory Investigation. 13(4). 665–667. 2 indexed citations
20.
Seppälä, Pentti, et al.. (1961). Chromatographic Pattern of Ninhydrin‐staining Compounds in Gastric Juice. Acta Medica Scandinavica. 170(2). 187–189. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026